EGF and lung carcinoma: Interestingly, when lung cancer cells were treated with EGF, we observed an increased proliferation that was reduced in a dose-dependent manner by both AvnA and AvnC (Figure 1), indicating a possible inhibitory role of Avns in EGF signalling pathway.